• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protect

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2025 Dec;21(1):2453304.
doi: 10.1080/21645515.2025.2453304. Epub 2025 Feb 16. An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protection against influenza a viruses in adult and aged mice

Liang Xu[SUP] 1 [/SUP], Zhihao Yu[SUP] 1 [/SUP], Yifan Xu[SUP] 1 [/SUP], Qin Wang[SUP] 1 [/SUP], Guiqin Wang[SUP] 2 [/SUP], Benchi Li[SUP] 1 [/SUP], Qian Weng[SUP] 1 [/SUP], Yongxiang Yi[SUP] 1 [/SUP], Junwei Li[SUP] 1 3 [/SUP]



Affiliations
Free article Abstract

Currently, vaccination with influenza vaccines is still an effective strategy to prevent infection by seasonal influenza virus. However, seasonal influenza vaccines frequently fail to induce effective immune protection against rapidly changing seasonal influenza viruses and emerging zoonotic influenza viruses. In addition, seasonal influenza vaccines may not confer potent protection in elderly and immunocompromised individuals. There is an urgent need to develop potent broad-spectrum influenza vaccines to address this problem. Herein, we designed an mRNA-based broad-spectrum influenza vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses. In both adult and aged mice, this universal influenza mRNA vaccine candidate stimulated robust T-cell and humoral immune responses and conferred effective protection against broad-spectrum influenza viruses in both adult and aged mice.

Keywords: HA2; M2e; aged mice; broad-spectrum influenza vaccine; cholera toxin subunit B; mRNA vaccine.

 
Back
Top Bottom